Search

everythinglearnresearchcommunity

for

Search:↓

Clofazimine may be effective for treating ashy dermatosis.

Oral betamethasone mini-pulses effectively treat moderate to severe alopecia areata with manageable side effects.

Weekly azathioprine pulse is a better alternative to corticosteroids for treating alopecia areata due to fewer side effects.

Mitoxantrone with a corticosteroid helps manage symptoms for some advanced prostate cancer patients but doesn't extend life.

Both creams are equally safe, but hydrocortisone may cause more visible blood vessels.

Long-term Imiquimod treatment causes initial skin inflammation that lessens over time, and topical corticosteroids reduce this inflammation and cytokines in a mouse model of psoriasis.

Systemic corticosteroids help manage vitiligo by slowing progression and aiding repigmentation.

Both azathioprine and betamethasone treatments effectively regrow hair in alopecia areata, but azathioprine may be safer.

Dexamethasone-primed stem cell media shows promise in treating lupus by reducing symptoms and inflammation.

Cal/BD aerosol foam effectively treats scalp psoriasis, improving symptoms and patient satisfaction.

Guidelines suggest various treatments for alopecia areata, but leaving it untreated is also an option as 80% cases may recover on their own.

The document concludes that developing generic topical drugs requires ensuring they match the original in quality, composition, and structure, and often involves complex testing and regulatory steps.

Some treatments can help with a hair loss condition called alopecia areata, but none ensure lasting results; choices depend on the person, with JAK inhibitors showing promise for severe cases.

The 2003 guidelines suggest that while some treatments can regrow hair in alopecia areata, none alter the disease's progression, and wigs may be the best option for extensive hair loss.

Current treatments for alopecia show no significant long-term benefits.

Alopecia areata causes hair loss, has no cure, and various treatments exist.

Clobetasol propionate ointment can help some people with total hair loss regrow hair.

Some treatments, like corticosteroids and sensitizing agents, can help with alopecia areata, but more high-quality research is needed.

Alopecia areata can cause unpredictable hair loss, and treatments like corticosteroids and minoxidil may help but have varying side effects.

There are still challenges in diagnosing and treating chronic skin diseases, but there is hope for future improvements.

New treatments for severe hair loss often fail, but some patients see hair regrowth with specific therapies, and treatment should be tailored to the individual's situation.

No treatments fully cure or prevent alopecia areata; some help but have side effects or need more research.

Some treatments work for common baldness, but there's less evidence for other hair loss types, and more research is needed.

Monochromatic light devices, especially the 308-nm excimer laser, are promising for treating alopecia areata but more research is needed.

Herbal products might promote hair growth with fewer side effects, but more research is needed to confirm their safety and effectiveness.

Different treatments for alopecia areata have unpredictable results and varying success rates.

Intralesional corticosteroids work best for mild alopecia areata, and DPCP works best for moderate to severe cases.

The document concludes that more research is needed to understand and treat Beard Alopecia Areata due to limited current knowledge and evidence.

Certain factors like allergies, nail problems, and hair loss patterns can predict how well someone with patchy hair loss will respond to skin cream treatments.

Clobetasol and pimecrolimus are similarly effective for alopecia areata, but pimecrolimus has fewer side effects and is preferred for long-term use.